AM966

Overview

AM966 is a high affinity, selective, oral LPA 1 -antagonist, inhibits LPA-stimulated intracellular calcium release ( IC 50 =17 nM).

Application

Products | Products > Disease Areas > Respiratory Disease | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Pulmonary Disease | Products > Disease Areas > Lung Fibrosis | Products > Signaling Pathways > GPCR/G Protein | Products > Research Areas > Inflammation/Immunology | Products > Signaling Pathways > LPL Receptor

Product Information

• Catalog No.: HY-15277
• CAS No.: 1228690-19-4
• Molecular Formula: C27H23ClN2O5
• Molecular Weight: 490.93
• Purity: 98.91%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 2 years , -20°C, 1 year
• Solubility: 2.5 mg/mL (5.09 mM); Suspended solution; Need ultrasonic
• Availability: In-stock

Source

Original product source